These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26664628)

  • 1. Cholesterol lowering effects of mono-lactose-appended β-cyclodextrin in Niemann-Pick type C disease-like HepG2 cells.
    Motoyama K; Hirai Y; Nishiyama R; Maeda Y; Higashi T; Ishitsuka Y; Kondo Y; Irie T; Era T; Arima H
    Beilstein J Org Chem; 2015; 11():2079-86. PubMed ID: 26664628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of multi-lactose-appended β-cyclodextrin and its cholesterol-lowering effects in Niemann-Pick type C disease-like HepG2 cells.
    Motoyama K; Nishiyama R; Maeda Y; Higashi T; Ishitsuka Y; Kondo Y; Irie T; Era T; Arima H
    Beilstein J Org Chem; 2017; 13():10-18. PubMed ID: 28179943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-Lowering Effect of Octaarginine-Appended β-Cyclodextrin in Npc1-Trap-CHO Cells.
    Motoyama K; Nishiyama R; Maeda Y; Higashi T; Kawaguchi Y; Futaki S; Ishitsuka Y; Kondo Y; Irie T; Era T; Arima H
    Biol Pharm Bull; 2016 Nov; 39(11):1823-1829. PubMed ID: 27601082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease.
    Maeda Y; Motoyama K; Nishiyama R; Higashi T; Onodera R; Nakamura H; Takeo T; Nakagata N; Yamada Y; Ishitsuka Y; Kondo Y; Irie T; Era T; Arima H
    Nanomaterials (Basel); 2019 May; 9(5):. PubMed ID: 31130658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactose-Appended Hydroxypropyl-β-Cyclodextrin Lowers Cholesterol Accumulation and Alleviates Motor Dysfunction in Niemann-Pick Type C Disease Model Mice.
    Nishida T; Yokoyama R; Kubohira Y; Maeda Y; Takeo T; Nakagata N; Takagi H; Ishikura K; Yanagihara K; Misumi S; Kishimoto N; Ishitsuka Y; Kondo Y; Irie T; Soga M; Era T; Onodera R; Higashi T; Motoyama K
    ACS Appl Bio Mater; 2022 May; 5(5):2377-2388. PubMed ID: 35506864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential mode of cholesterol inclusion with 2-hydroxypropyl-cyclodextrins increases safety margin in treatment of Niemann-Pick disease type C.
    Yamada Y; Ishitsuka Y; Kondo Y; Nakahara S; Nishiyama A; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Kamei S; Shuto T; Kai H; Hayashino Y; Sugita M; Kikuchi T; Hirata F; Miwa T; Takeda H; Orita Y; Seki T; Ohta T; Kurauchi Y; Katsuki H; Matsuo M; Higaki K; Ohno K; Matsumoto S; Era T; Irie T
    Br J Pharmacol; 2021 Jul; 178(13):2727-2746. PubMed ID: 33782944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann-Pick Type C Using Quantitative Proteomics.
    Cougnoux A; Pergande MR; Serna-Perez F; Cologna SM
    J Am Soc Mass Spectrom; 2023 Apr; 34(4):668-675. PubMed ID: 36920149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent.
    Yokoo M; Kubota Y; Motoyama K; Higashi T; Taniyoshi M; Tokumaru H; Nishiyama R; Tabe Y; Mochinaga S; Sato A; Sueoka-Aragane N; Sueoka E; Arima H; Irie T; Kimura S
    PLoS One; 2015; 10(11):e0141946. PubMed ID: 26535909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-Pick Type C disease.
    Kondo Y; Tokumaru H; Ishitsuka Y; Matsumoto T; Taguchi M; Motoyama K; Higashi T; Arima H; Matsuo M; Higaki K; Ohno K; Irie T
    Mol Genet Metab; 2016 Jul; 118(3):214-219. PubMed ID: 27184436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann-Pick C1 mutant cell via lysosome-associated membrane protein 1.
    Singhal A; Szente L; Hildreth JEK; Song B
    Cell Death Dis; 2018 Oct; 9(10):1019. PubMed ID: 30282967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in
    Hoque S; Kondo Y; Sakata N; Yamada Y; Fukaura M; Higashi T; Motoyama K; Arima H; Higaki K; Hayashi A; Komiya T; Ishitsuka Y; Irie T
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyrotaxane-based systemic delivery of β-cyclodextrins for potentiating therapeutic efficacy in a mouse model of Niemann-Pick type C disease.
    Tamura A; Yui N
    J Control Release; 2018 Jan; 269():148-158. PubMed ID: 29138063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactose-appended β-cyclodextrin as an effective nanocarrier for brain delivery.
    Yokoyama R; Taharabaru T; Nishida T; Ohno Y; Maeda Y; Sato M; Ishikura K; Yanagihara K; Takagi H; Nakamura T; Ito S; Ohtsuki S; Arima H; Onodera R; Higashi T; Motoyama K
    J Control Release; 2020 Dec; 328():722-735. PubMed ID: 33002523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine-tuned cholesterol solubilizer, mono-6-O-α-D-maltosyl-γ-cyclodextrin, ameliorates experimental Niemann-Pick disease type C without hearing loss.
    Yamada Y; Miwa T; Nakashima M; Shirakawa A; Ishii A; Namba N; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Kurauchi Y; Seki T; Katsuki H; Okada Y; Ichikawa A; Higaki K; Hayashi K; Minami K; Yoshikawa N; Ikeda R; Ishikawa Y; Kajii T; Tachii K; Takeda H; Orita Y; Matsuo M; Irie T; Ishitsuka Y
    Biomed Pharmacother; 2022 Nov; 155():113698. PubMed ID: 36116252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells.
    Rosenbaum AI; Zhang G; Warren JD; Maxfield FR
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5477-82. PubMed ID: 20212119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Cyclodextrin-threaded biocleavable polyrotaxanes ameliorate impaired autophagic flux in Niemann-Pick type C disease.
    Tamura A; Yui N
    J Biol Chem; 2015 Apr; 290(15):9442-54. PubMed ID: 25713067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained Release Formulation of Hydroxypropyl-β-cyclodextrin Eye Drops Using Xanthan Gum.
    Higashi T; Goto T; Onodera R; Hirotsu T; Ikeda HO; Motoyama K
    Chem Pharm Bull (Tokyo); 2024; 72(4):381-384. PubMed ID: 38616116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic Acid-Appended Hydroxypropyl-β-Cyclodextrin Exhibits Potent Antitumor Activity in Chronic Myeloid Leukemia Cells via Autophagic Cell Death.
    Hoshiko T; Kubota Y; Onodera R; Higashi T; Yokoo M; Motoyama K; Kimura S
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded access with intravenous hydroxypropyl-β-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis.
    Hastings C; Vieira C; Liu B; Bascon C; Gao C; Wang RY; Casey A; Hrynkow S
    Orphanet J Rare Dis; 2019 Oct; 14(1):228. PubMed ID: 31639011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of the Anionic Hydroxypropyl-β-cyclodextrin:Poly(decamethylenephosphate) Polyrotaxane and Evaluation of its Cholesterol Efflux Potential in Niemann-Pick C1 Cells.
    Egele K; Samaddar S; Schneider N; Thompson D; Wenz G
    J Mater Chem B; 2019 Jan; 7(4):528-537. PubMed ID: 31372225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.